Gilead Sciences
GILD
#122
Rank
NZ$275.43 B
Marketcap
NZ$221.84
Share price
-1.88%
Change (1 day)
23.89%
Change (1 year)

EPS for Gilead Sciences (GILD)

EPS in 2025 (TTM): NZ$11.73

According to Gilead Sciences's latest financial reports the company's current EPS (TTM) is NZ$11.73. In 2024 the company made an earnings per share (EPS) of NZ$0.65 a decrease over its 2023 EPS that were of NZ$7.79.

EPS history for Gilead Sciences from 2012 to 2025

Annual EPS

Year EPS Change
2025 (TTM)NZ$11.731702.99%
2024NZ$0.65-91.65%
2023NZ$7.7923.98%
2022NZ$6.28-25.86%
2021NZ$8.474850%
2020NZ$0.17-97.64%
2019NZ$7.260.9%
2018NZ$7.1918.71%
2017NZ$6.06-64.88%
2016NZ$17.26-18.45%
2015NZ$21.1655.28%
2014NZ$13.63296.02%
2013NZ$3.4417.89%
2012NZ$2.92

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
NZ$14.96 27.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
NZ$2.24-80.88%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
NZ$3.52-69.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$48.32 312.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$24.79 111.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
NZ$16.01 36.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
NZ$9.47-19.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
NZ$29.12 148.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$6.09-48.07%๐Ÿ‡บ๐Ÿ‡ธ USA